BioForce Nanosciences Holdings (BFNH)
OTHER OTC:BFNH
Total Valuation
BioForce Nanosciences Holdings has a market cap or net worth of $44.28M. The enterprise value is $22.14M.
Market Cap$44.28M
Enterprise Value$22.14M
Share Statistics
BioForce Nanosciences Holdings has 33,549,004 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,549,004
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioForce Nanosciences Holdings’s return on equity (ROE) is 2.09 and return on invested capital (ROIC) is 79.21%.
Return on Equity (ROE)2.09
Return on Assets (ROA)-1.64K
Return on Invested Capital (ROIC)79.21%
Return on Capital Employed (ROCE)0.79
Revenue Per Employee0.00
Profits Per Employee-430.65K
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioForce Nanosciences Holdings is ―. BioForce Nanosciences Holdings’s PEG ratio is -0.11.
PE Ratio―
PS Ratio0.00
PB Ratio-31.14
Price to Fair Value-31.14
Price to FCF-295.63
Price to Operating Cash Flow-1.03K
PEG Ratio-0.11
Income Statement
In the last 12 months, BioForce Nanosciences Holdings had revenue of 0.00 and earned -1.29M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit0.00
Operating Income-489.95K
Pretax Income-489.95K
Net Income-1.29M
EBITDA-489.95K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -42.85K and capital expenditures 0.00, giving a free cash flow of -42.85K billion.
Operating Cash Flow-42.85K
Free Cash Flow-42.85K
Free Cash Flow per Share>-0.01
Dividends & Yields
BioForce Nanosciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.15
52-Week Price Change199.81%
50-Day Moving Average0.68
200-Day Moving Average0.64
Relative Strength Index (RSI)70.21
Average Volume (3m)990.00
Important Dates
BioForce Nanosciences Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioForce Nanosciences Holdings as a current ratio of <0.01, with Debt / Equity ratio of 0.00%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioForce Nanosciences Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioForce Nanosciences Holdings EV to EBITDA ratio is -39.31, with an EV/FCF ratio of -295.62.
EV to Sales0.00
EV to EBITDA-39.31
EV to Free Cash Flow-295.62
EV to Operating Cash Flow-295.62
Balance Sheet
BioForce Nanosciences Holdings has $6.35K in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.35K billion.
Cash & Marketable Securities$6.35K
Total Debt$0.00
Net Cash$6.35K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioForce Nanosciences Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast66.83%